SCHEMBL6401138

SCHEMBL6401138

CC(CC(=O)c1ccc(O)cc1SP(=O)(O)O)c1ccc(O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.36
ESR2 Q92731 4/20 0.36
HSP90AB1 P08238 1/20 0.35
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ACHE P22303 1/20 0.33
CYP3A4 P08684 1/20 0.33
PPARG P37231 1/20 0.33
SHBG P04278 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
MIF P14174 1/20 0.33
ALDH1A1 P00352 1/20 0.32
GFER P55789 1/20 0.32
PDCD1 Q15116 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6397676 0.91 ESR1 (0.36) ESR1ESR2HSP90AB1MAPTMEN1
SCHEMBL6394995 0.89 HIF1A (0.35) HSP90AB1MAPTMIF
SCHEMBL6404290 0.84 MEN1 (0.36) ESR1ESR2MAPTMEN1KMT2A
SCHEMBL6403934 0.81 CYP3A4 (0.49) ESR1ESR2HSP90AB1MAPTMEN1
SCHEMBL6401143 0.81 ESR1 (0.38) ESR1ESR2HSP90AB1MAPTMEN1
SCHEMBL6394689 0.80 HIF1A (0.34) ESR1ESR2MIF
SCHEMBL6397752 0.79 FFAR1 (0.35) ESR1ESR2ACHECA12CA1
SCHEMBL6401985 0.78 ESR1 (0.45) ESR1ESR2MAPTCYP3A4MIF
SCHEMBL6397684 0.78 ESR1 (0.38) ESR1ESR2HSP90AB1MAPTMEN1
SCHEMBL6403777 0.78 MEN1 (0.41) ESR1ESR2HSP90AB1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 ESR1 2885/4885ESR2 2416/4885HSP90AB1 2401/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 ESR1 2885/4885ESR2 2416/4885HSP90AB1 2401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.